𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Determinants of spontaneous surface antigen loss in hepatitis B e antigen–negative patients with a low viral load

✍ Scribed by Tai-Chung Tseng; Chun-Jen Liu; Hung-Chih Yang; Tung-Hung Su; Chia-Chi Wang; Chi-Ling Chen; Stephanie Fang-Tzu Kuo; Chen-Hua Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
659 KB
Volume
55
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A molecular analysis of viral persistenc
A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B
✍ J Kato; K Hasegawa; N Torii; K Yamauchi; N Hayashi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

To identify the mechanisms of viral persistence in coincides with the cessation of hepatocyte injury. 1,2 Howpatients with chronic hepatitis B after the acquisition ever, with current molecular biological techniques, trace of anti -hepatitis B surface antigen antibodies (anticoncentrations of HBV DN

Characterization of viral kinetics in pa
Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B
✍ I-Chin Wu; Nan-Haw Chow; Pin-Nan Cheng; Wen-Chun Liu; Kung-Chia Young; Wei-Lun C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract A study was conducted during a 1 year follow‐up to characterize the viral kinetics in hepatitis B e antigen (HBeAg)‐positive chronic hepatitis B and to develop a model of predicting the probability of spontaneous HBeAg seroconversion. Fifty‐seven patients with HBeAg‐positive chronic hep

Serum hepatitis B surface antigen and he
Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
✍ Alexander J.V. Thompson; Tin Nguyen; David Iser; Anna Ayres; Kathy Jackson; Marg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Although threshold levels for hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) titers have recently been proposed to guide therapy for chronic hepatitis B (CHB), their relationship to circulating hepatitis B virus (HBV) DNA and intrahepatic HBV replicative intermediates, and the

Detection of hepatitis B viral DNA by po
Detection of hepatitis B viral DNA by polymerase chain reaction in patients with hepatitis B surface antigen
✍ Ling-Na Shih; Jin-Chuan Sheu; Jin-Town Wang; Guan-Tarn Huang; Juei-Suei Chen; Ju 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 690 KB

## Abstract Hepatitis B virus (HBV) DNA was assayed using the polymerase chain reaction in serum samples of 116 hepatitis B surface antigen (HBsAg) carriers, including 30 positive for hepatitis B e antigen (HBeAg) and 86 negative for HBeAg. In the HBeAg‐positive group, all were positive for HBV DNA

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60